MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
kegg.drug:D10306 keggD:D10306 OFZJKCQENFPZBH-UHFFFAOYSA-N | Avatrombopag (USAN/INN) |
| hmdb:HMDB0248737 OFZJKCQENFPZBH-UHFFFAOYSA-N | Avatrombopag 1-(3-Chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]-C-hydroxycarbonimidoyl}pyridin-2-yl)piperidine-4-carboxylate 1-(3-chloro-5-((4-(4-chloro-2-Thienyl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)-2-pyridyl)piperidine-4-carboxylic acid 1-(3-chloro-5-{[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl}pyridin-2-yl)piperidine-4-carboxylic acid AKR 501 AKR-501 e5501 e5501 Compound |
keggD:M_D10306 | secondary/obsolete/fantasy identifier |